Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8133 USD | -4.31% | -4.32% | -32.23% |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.68M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.1
x | P/E ratio 2024 * |
-0.11
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.63% |
Latest transcript on Eloxx Pharmaceuticals, Inc.
1 day | -4.31% | ||
1 week | -4.32% | ||
Current month | -15.38% | ||
1 month | -21.80% | ||
3 months | +8.44% | ||
6 months | -28.66% | ||
Current year | -32.23% |
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.8133 | -4.31% | 31,395 |
24-05-08 | 0.85 | -1.16% | 3,003 |
24-05-07 | 0.86 | +0.58% | 1,293 |
24-05-06 | 0.855 | -5.00% | 4,397 |
24-05-03 | 0.9 | +5.88% | 1,651 |
Delayed Quote OTC Markets, May 09, 2024 at 03:33 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.23% | 2.68M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.18% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- ELOX Stock